Cutaneous application of leukotriene B4 as an in vivo model of psoriasis-like skin inflammation: An immunohistological study

Skin Pharmacology and Physiology

Volumn 27, Issue 3, 2014, Pages 120-126

  Hendriks, A G M ^a   Keijsers, R R M C ^a   Seyger, M M B ^a   Van De Kerkhof, P C M ^a   Van Erp, P E J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Interleukin 17; Leukotriene B4; Polymorphonuclear leucocytes; Psoriasis; T helper 1 cells

Indexed keywords

BETA DEFENSIN 2; CYTOKERATIN 10; CYTOKERATIN 16; ELAFIN; INTERLEUKIN 17; KI 67 ANTIGEN; LEUKOCYTE ELASTASE; LEUKOTRIENE B4; TRANSCRIPTION FACTOR T BET;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; BIOLOGICAL ACTIVITY; CELL INFILTRATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; DERMATITIS; EPIDERMIS; EPIDERMIS CELL; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOHISTOLOGY; IN VIVO STUDY; INNATE IMMUNITY; KERATINOCYTE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PSORIASIS; REPRODUCIBILITY; STATISTICAL SIGNIFICANCE; BIOLOGICAL MODEL; CLINICAL TRIAL; IMMUNOLOGY; INFLAMMATION; MIDDLE AGED; PATHOLOGY; SKIN; TH1 CELL; TH17 CELL; YOUNG ADULT;

ADULT; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-17; LEUKOTRIENE B4; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PSORIASIS; REPRODUCIBILITY OF RESULTS; SKIN; TH1 CELLS; TH17 CELLS; YOUNG ADULT;

EID: 84891695850     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000354119     Document Type: Article

References (26)

1. Griffiths CE, Barker JN: Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-271.
2. Blauvelt A: T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis. J Invest Dermatol 2008; 128: 1064-1067.
3. Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, Pierson KC, Gonzalez J, Krueger JG, Lowes MA: Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 2009; 129: 79-88.
4. Eid RE, Rao DA, Zhou J, Lo SF, Ranjbaran H, Gallo A, Sokol SI, Pfau S, Pober JS, Tellides G: Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009; 119: 1424-1432.
5. Miossec P: IL-17 and Th17 cells in human inflammatory diseases. Microbes Infect 2009; 11: 625-630.
6. Leonardi C, Matheson R, Zachariae C, Cameron G, Li L, Edson-Heredia E, Braun D, Banerjee S: Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 2012; 366: 1190-1199.
7. Papp KA, Leonardi C, Menter A, Ortonne JP, Krueger JG, Kricorian G, Aras G, Li J, Russell CB, Thompson EH, Baumgartner S: Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med 2012; 366: 1181-1189.
8. De Jong EM, van Erp PE, van Vlijmen IM, van de Kerkhof PC: The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B 4-an immunohistochemical study. Clin Exp Dermatol 1992; 17: 413-420.
9. Seyger MM, van Pelt JP, van den Born J, Latijnhouwers MA, de Jong EM: Epicutaneous application of leukotriene B 4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions. Arch Dermatol Res 1997; 289: 331-336.
10. Camp R, Jones RR, Brain S, Woollard P, Greaves M: Production of intraepidermal microabscesses by topical application of leukotriene B 4 . J Invest Dermatol 1984; 82: 202-204.
11. Winkelmann RK, Camp R, English JS, Greaves MW: The perivascular cell populations in human skin after topical application of leukotriene B 4 . Acta Derm Venereol 1986; 66: 340-343.
12. Bauer FW, van de Kerkhof PC, Maassen-de Grood RM: Epidermal hyperproliferation following the induction of microabscesses by leukotriene B 4 . Br J Dermatol 1986; 114: 409-412.
13. Ruzicka T, Simmet T, Peskar BA, Ring J: Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol 1986; 86: 105-108.
14. Ziboh VA, Casebolt TL, Marcelo CL, Voorhees JJ: Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin. J Invest Dermatol 1984; 83: 426-430.
15. Yokomizo T, Izumi T, Shimizu T: Leukotriene B 4 : metabolism and signal transduction. Arch Biochem Biophys 2001; 385: 231-241.
16. Murphy RC, Gijon MA: Biosynthesis and metabolism of leukotrienes. Biochem J 2007; 405: 379-395.
17. Friedrich EB, Tager AM, Liu E, Pettersson A, Owman C, Munn L, Luster AD, Gerszten RE: Mechanisms of leukotriene B 4-triggered monocyte adhesion. Arterioscler Thromb Vasc Biol 2003; 23: 1761-1767.
18. Ruifrok AC, Johnston DA: Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 2001; 23: 291-299.
19. Gerritsen MJ, van Erp PE, van Vlijmen-Willems IM, Lenders LT, van de Kerkhof PC: Repeated tape stripping of normal skin: a histological assessment and comparison with events seen in psoriasis. Arch Dermatol Res 1994; 286: 455-461.
20. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH: A novel transcription factor, T-Bet, directs Th1 lineage commitment. Cell 2000; 100: 655-669.
21. De Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, Idu MM, van Maldegem F, Aten J, van der Wal AC: Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. J Pathol 2010; 220: 499-508.
22. Hueber AJ, Asquith DL, Miller AM, Reilly J, Kerr S, Leipe J, Melendez AJ, McInnes IB: Mast cells express IL-17a in rheumatoid arthritis synovium. J Immunol 2010; 184: 3336-3340.
23. Keijsers RR, van der Velden HM, van Erp PE, de Boer-van Huizen RT, Joosten I, Koenen HJ, van de Kerkhof PC: Balance of T reg versus T-helper cells in the transition from symptomless to lesional psoriatic skin. Br J Dermatol 2013; 168: 1294-1302.
24. Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, Villanueva EC, Shah P, Kaplan MJ, Bruce AT: Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 2011; 187: 490-500.
25. Christophers E: Explaining phenotype heterogeneity in patients with psoriasis. Br J Dermatol 2008; 158: 437-441.
26. Choe YB, Hwang YJ, Hahn HJ, Jung JW, Jung HJ, Lee YW, Ahn KJ, Youn JI: A comparison of serum inflammatory cytokines according to phenotype in patients with psoriasis. Br J Dermatol 2012; 167: 762-767.